Randone Trial: Friend Details Lee's Drug Habits

Felicia Lee's best friend took the stand Monday in the and testified about taking drugs with the former adult film star.

Shannon Donnan, who said she was best friends with Lee for about four years before her death, testified Monday that she and Lee would take the drug GHB together at parties that sometimes lasted for days.

Randone's attorneys , but the medical examiner who performed her autopsy determined that the 31-year-old was smothered to death.

Donnan said Lee would take GHB during parties while also using cocaine or crystal methamphetamine. She never became violent while using the drugs, she said.

"She wanted to have fun," Donnan said. "She wasn't aggressive in any form."

Randone's attorneys have argued that Lee's hundreds of wounds were caused while in the process of a drug overdose. She had 320 separate blunt force trauma wounds throughout her body, prosecutors said.

Donnan testified that Lee would always take the same amount of GHB when they partied together and said she was very "responsible" about the regimen. She liked to dance while on the drug and would also sometimes rollerskate, Donnan said.

"She was a goofball naturally and she was even sillier while we were high," Donnan said.

In her only reference to Randone, Donnan said that she saw much less of her friend when she began dating him. Lee met Randone in Las Vegas in May 2009, she said.

"It went from her being at my home at least three days a week to not seeing her for three weeks at a time," she testified.

Before Donnan took the stand, Randone's attorneys continued to cross-examine Dr. Ajay Panchal, the medical examiner from the Los Angeles County Department of Coroner .

Panchal insisted that the wounds throughout Lee's body could not have been self-inflicted over the course of a drug overdose. He said Friday that the wounds on Lee's face indicated that she was smothered to death.

"My conclusion is that clearly it's a homicide," Panchal testified Monday.

Keep checking Patch for the latest coverage of the Randone trial.